IBD: Ulcerative Colitis

Benefit and Risk Assessment Tool for IBD Treatments

Tags:

 

This e-learning tool was made possible due to an unrestricted educational grant from Pfizer Canada

Benefit and Risk Assessment Tool for IBD Treatments

[iframe_loader type='iframe' width='100%' height='600' frameborder='0' scrolling='no' src='/wp-content/uploads/articulate_uploads/IBD-Benefits-and-Risk-Assesment-Tool4/story.html']  

This e-learning tool was made possible due to an unrestricted educational grant from Pfizer Canada